Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative 1)

v3.5.0.2
Notes Payable (Details Narrative 1)
 1 Months Ended 6 Months Ended
Nov. 30, 2010
USD ($)
Number
shares
Jun. 30, 2016
USD ($)
shares
Dec. 31, 2015
USD ($)
Debt Instrument [Line Items]      
Common stock fair value | $ $ 2,775,300    
Unamortized discount | $   $ 2,539,510  
Officer [Member]      
Debt Instrument [Line Items]      
Number of unit issued 22,068    
Number of officers and directors | Number 4    
Value of unit issued 247,164    
Non-Employee Directors [Member]      
Debt Instrument [Line Items]      
Number of unit issued 14,180    
Number of officers and directors | Number 3    
Value of unit issued 158,816    
2010 Junior Secured Notes Payable [Member]      
Debt Instrument [Line Items]      
Description of unit

Units consisting of a junior secured note (the “2010 Secured Notes”) and one share of the Company’s common stock.

    
Number of unit issued 267,857    
Debt face amount | $ $ 3,000,000    
Description of maturity date

Mature in November 2020

    
Stated interest rate 3.50%    
Description of collateral terms

Collateralized by a security interest in the assets of the Company, which security interest is junior and subordinate to the security interests that collateralize the Brainlab Note and the 2014 Secured Notes.

    
Description of payment terms

Interest on the 2010 Secured Notes will be due and payable in a single payment upon maturity.

    
Unamortized discount | $ $ 2,775,300 2,427,789 $ 2,535,230
Interest expense terms

10-year term of the notes using the effective interest method.

    
New Brainlab Note (amended and restated secured note) [Member]      
Debt Instrument [Line Items]      
Principal and accrued interest | $   $ 2,000,000  
Number of warrants issued   46,207